Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose …
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose …
Use of convalescent plasma in COVID‐19 patients with immunosuppression
In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis
Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …
mortality associated with coronavirus disease 2019 (COVID-19) because they less …
Treatment of chronic or relapsing COVID-19 in immunodeficiency
LAK Brown, E Moran, A Goodman, H Baxendale… - Journal of Allergy and …, 2022 - Elsevier
Background Patients with some types of immunodeficiency can experience chronic or
relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
MS Buckland, JB Galloway, CN Fhogartaigh… - Nature …, 2020 - nature.com
The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study
ES Goudouris, F Pinto-Mariz, LO Mendonca… - Journal of clinical …, 2021 - Springer
Purpose There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of
Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of …
Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of …
COVID-19 in B cell-depleted patients after rituximab: a diagnostic and therapeutic challenge
A Furlan, G Forner, L Cipriani, E Vian, R Rigoli… - Frontiers in …, 2021 - frontiersin.org
B cell-targeting strategies such as rituximab are widely used in B cell hematologic
malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune …
malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune …
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Since the arrival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
December 2019, its characterization as a novel human pathogen, and the resulting …
December 2019, its characterization as a novel human pathogen, and the resulting …
Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel
N Marcus, S Frizinsky, D Hagin, A Ovadia… - Frontiers in …, 2021 - frontiersin.org
In the last few months the world has witnessed a global pandemic due to severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …
Convalescent plasma therapy for COVID-19: a graphical mosaic of the worldwide evidence
Convalescent plasma has been used worldwide to treat patients hospitalized with
coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global …
coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global …